GLP-1s: The Medications Redefining Diabetes and Obesity Treatment

(MedPage Today) — In part one of this three-part Instagram Live discussion, MedPage Today editor-in-chief Jeremy Faust, MD, talks about how GLP-1 receptor agonists are transforming diabetes and obesity care in a discussion with Karl Nadolsky…

Powered by WPeMatico